Looking ahead to future neurotherapeutics
Innovation is a core value of ABAXYS Therapeutics.
Aiming to provide innovation in the discovery of new medicines for huge unmet medical needs, our programs ABXY-2 and ABX-4 successfully advance into preclinical development. These early programs entering into hit-to-lead aim to deliver POC for epilepsy and neurodegeneration. They will strengthen ABAXYS’ efforts to cure human brain diseases.
